Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City

NCT ID: NCT03397511

Last Updated: 2019-11-08

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 10 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-09-05
• Study Completion Date: 2019-10-01

Brief Summary

Financial incentives for motivating health change have been increasingly employed in various healthcare sectors. They can be a potentially effective approach to promote smoking behavioral change and increase the use of evidence-based counseling and pharmacotherapy. Smoking cessation randomized clinical trials (RCT) incorporating financial incentives have been conducted in different populations; however, there has not been a randomized clinical trial coupled with a financial incentive with Asian American cigarette smokers. The purpose of this pilot study is to examine the feasibility of implementing an incentivized smoking cessation program among Asian American smokers in New York City.

Conditions

Smoking Cessation; Smoking, Cigarette

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Usual Care+Financial Incentive

Smoking cessation counseling couples with financial incentives

Group Type: EXPERIMENTAL

Financial Incentives

Intervention Type: BEHAVIORAL

Baseline Interview, 2 Counseling Sessions at baseline and 2 weeks post baseline, and one follow up survey at one month

Interventions

Financial Incentives

Baseline Interview, 2 Counseling Sessions at baseline and 2 weeks post baseline, and one follow up survey at one month

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Asian American
• current smoker who smokes at least 10 cigarettes daily (verified by a CO level of 8 ppm or above)
• New York City resident
• able to complete three month follow-up assessments in person, can provide a telephone number
• declining the use of Chantix for smoking cessation.

Exclusion Criteria

• <18 years old
• pregnant
• cannot provide a telephone number, non-smokers or smokers that smoke fewer than 10 cigarettes daily, users of e-cigarettes or other tobacco products who are not interested in quitting smoking, marijuana users
• not a New York City resident
• unable to complete three month follow-up assessment in person
• unable to provide written consent
• agree to use Chantix for smoking cessation.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

NYU Langone Health

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Donna Shelley, MD

Role: PRINCIPAL_INVESTIGATOR

NYU Langone Health

Locations

New York University School of Medicine

New York, New York, United States

Countries

United States

Other Identifiers

17-00760

Identifier Type: -

Identifier Source: org_study_id